DIAGNODE-2 clinical trial Investigator Meeting in Barcelona

6 oktober 2017 Spain

DIAGNODE-2 clinical trial Investigator Meeting in Barcelona

Diamyd Medical arranges a two days Investigator Meeting for the European Phase II study DIAGNODE-2 attended by investigators, diabetes nurses, study managers and coordinators from Czech Republic, Sweden and Spain.
Professor Johnny Ludvigsson, Coordinating Investigator of the diabetes trial DIAGNODE-2, is leading the meeting held in Barcelona, Spain. The participants are presented to trial design, protocol and study management as a part of the preparation of the trial start and patient recruitment.

About DIAGNODE-2
The placebo controlled phase II clinical trial DIAGNODE-2 will include approximately 80 patients from Spain, the Czech Republic and Sweden aged 12-24 years, recently diagnosed with type 1 diabetes. The patients will be followed for 15 months with the aim to evaluate the remaining insulin producing capacity.

Investigators, nurses, CRAs, study coordinators and managers from Spain, Czech republic and Sweden participating in the DIAGNODE-2 Investigators Meeting arranged by the trial sponsor Diamyd Medical, held in Barcelona 5-6 October 2017.

Information som presenteras här är inte pressmeddelanden och kan innehålla utdrag ur och länkar till externt publicerat innehåll. Diamyd Medical ansvarar inte för externt publicerat innehåll.

Fler artiklar

Professor Johnny Ludvigsson, Linköpings universitet, presenting the diabetes trial DIAGNODE-2 and the innovative and patent pending concept where the diabetes vaccine Diamyd® is administered directly into the lymph node.